Interleukin-6 gene amplification and shortened survival in glioblastoma patients
Open Access
- 16 January 2007
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 96 (3), 474-476
- https://doi.org/10.1038/sj.bjc.6603586
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prognostic impact of molecular markers in a series of 220 primary glioblastomasCancer, 2006
- Overexpressed Skp2 within 5p amplification detected by array‐based comparative genomic hybridization is associated with poor prognosis of glioblastomasCancer Science, 2005
- Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition toEGFR in glioblastoma multiformeGenes, Chromosomes and Cancer, 2005
- Interleukin‐6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1International Journal of Cancer, 2005
- Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.2003
- Clinical implications of quantitative real-time RT–PCR analysis of hTERT gene expression in human gliomasBritish Journal of Cancer, 2003
- Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells.2001
- IL-6 gene amplification and expression in human glioblastomasBritish Journal of Cancer, 2001
- Interleukin-6 overexpression as a marker of malignancy in human gliomasJournal of Neurosurgery, 2001
- Interleukin‐6‐Mediated Autocrine Growth Promotion in Human Glioblastoma Multiforme Cell Line U87MGJournal of Neurochemistry, 1998